1. OC.01.4 THREE YEARS OF OBETICHOLIC ACID (OCA) THERAPY RESULTS IN HISTOLOGICAL IMPROVEMENTS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: FURTHER ANALYSIS OF THE POISE BIOPSY SUBSTUDY. (25th March 2019) Authors: Bowlus, C.L.; Pockros, P.; Kremer, A.; Pares, A.; Forman, L.M.; Drenth, J.P.; Ryder, S.; Floreani, A.; Terracciano, L.; Jin, Y.; Lieberman, A.; Pencheck, R.; Iloeje, U.; Macconell, L.; Bedossa, P. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 2 Page Start: e78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. T06.01.3 DURABLE RESPONSE IN THE MARKERS OF CHOLESTASIS THROUGH 5 YEARS OF OPEN-LABEL EXTENSION STUDY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS. (1st October 2020) Authors: Nevens, F.; Mitchell, S.; Drenth, J.P.; Bowlus, C.L.; Vargas, V.; Andreone, P.; Van Erpecum, K.; Floreani, A.; Lieberman, A.; Pencheck, R.; Smoot Malecha, E. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗